The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)
Clinical trial NCT06476210 · UNKNOWN
Trial details
- NCT number
- NCT06476210
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.